Tao K, Ye L, Xu Y, Yang M, Yin R, Li Q
Front Oncol. 2025; 15:1464368.
PMID: 39963113
PMC: 11830601.
DOI: 10.3389/fonc.2025.1464368.
Van Arsdale A, Mescheryakova O, Gallego S, Maggi E, Harmon B, Kuo D
medRxiv. 2025; .
PMID: 39830266
PMC: 11741462.
DOI: 10.1101/2024.09.16.24313343.
Chitoran E, Bohiltea R, Rotaru V, Durdu C, Mitroiu M, Simion L
Medicina (Kaunas). 2025; 60(12.
PMID: 39768893
PMC: 11728026.
DOI: 10.3390/medicina60122013.
Ishikawa H, Monma M, Ishimori Y, Saotome K, Ishii S, Sekino H
Radiol Phys Technol. 2024; 18(1):127-135.
PMID: 39592558
DOI: 10.1007/s12194-024-00861-3.
Benseler A, Vicus D, Covens A, Kupets R, Parra-Herran C, Gien L
Int J Gynaecol Obstet. 2024; 168(3):1258-1263.
PMID: 39400341
PMC: 11823354.
DOI: 10.1002/ijgo.15937.
Potential mechanisms of ZiGongDing in treating HPV-induced cervical intraepithelial neoplasia: a network pharmacology and experimental verification study.
Wan L, Chen K, Ma X, Han L, Xie Q, Wang L
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39325153
DOI: 10.1007/s00210-024-03445-5.
Hematological indicator-based machine learning models for preoperative prediction of lymph node metastasis in cervical cancer.
Zhao H, Wang Y, Sun Y, Wang Y, Shi B, Liu J
Front Oncol. 2024; 14:1400109.
PMID: 39193382
PMC: 11347340.
DOI: 10.3389/fonc.2024.1400109.
Comparing qSMI and qCEUS for assessing vascularization in uterine cervical cancer: operable versus non-operable group.
Zhu Y, Li Y, Tang Y, Zhang J, Jia S, Jiang Z
Front Oncol. 2024; 14:1380725.
PMID: 39188687
PMC: 11345174.
DOI: 10.3389/fonc.2024.1380725.
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning.
Han G, Kim H, Yun H, Chung J, Kim J, Cho H
Am J Cancer Res. 2024; 14(6):3186-3197.
PMID: 39005664
PMC: 11236797.
DOI: 10.62347/MTER1763.
Association of albumin, neutrophil-lymphocyte ratio and lymphocytes with clinical stage in cervical cancer patients.
Perez-Cruz E, Howlet-Caballero L, Villanueva X
Clin Transl Oncol. 2024; 27(2):687-692.
PMID: 39002067
DOI: 10.1007/s12094-024-03575-5.
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients.
Quan C, Zheng Z, Cao S, Wu Y, Zhang W, Huang Y
J Gynecol Oncol. 2024; 35(4):e98.
PMID: 38725236
PMC: 11262902.
DOI: 10.3802/jgo.2024.35.e98.
Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
Zhang W, Yu H, Xiu Y, Meng F, Wang Z, Zhao K
Technol Cancer Res Treat. 2024; 23:15330338241254075.
PMID: 38720626
PMC: 11085003.
DOI: 10.1177/15330338241254075.
Analysis of Risk Factors of Postoperative Lower Extremity Deep Venous Thrombosis in Patients With Cervical Cancer.
Cheng S, Gao H, Li Y, Shi X, Li X, Yang T
Clin Appl Thromb Hemost. 2024; 30:10760296241240747.
PMID: 38528746
PMC: 10964453.
DOI: 10.1177/10760296241240747.
The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023).
Fischerova D, Fruhauf F, Burgetova A, Haldorsen I, Gatti E, Cibula D
Cancers (Basel). 2024; 16(4).
PMID: 38398166
PMC: 10886638.
DOI: 10.3390/cancers16040775.
Hypermethylated CDO1 and CELF4 in cytological specimens as triage strategy biomarkers in endometrial malignant lesions.
Qi B, Sun Y, Lv Y, Hu P, Ma Y, Gao W
Front Oncol. 2023; 13:1289366.
PMID: 38107069
PMC: 10722236.
DOI: 10.3389/fonc.2023.1289366.
Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer.
Huang X, Li J, Pang X, Zhu J, Pan J, Li Y
Clin Transl Sci. 2023; 16(12):2519-2529.
PMID: 38013655
PMC: 10719482.
DOI: 10.1111/cts.13642.
The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients.
Sharbatoghli M, Saeednejad Zanjani L, Fahimeh F, Kalantari E, Habibi Shams Z, Panahi M
Iran J Pathol. 2023; 18(3):312-326.
PMID: 37942198
PMC: 10628370.
DOI: 10.30699/IJP.2023.554227.2901.
Potential diagnostic value of quantitative superb microvascular imaging in premalignant and malignant cervical lesions.
Zhu Y, Tang Y, Jiang Z, Zhang J, Jia S, Li Y
Front Oncol. 2023; 13:1250842.
PMID: 37692857
PMC: 10492516.
DOI: 10.3389/fonc.2023.1250842.
Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk.
Ye L, Wang D, Yang M, Li Q, Luo H, Lin X
Front Oncol. 2023; 13:1173838.
PMID: 37614506
PMC: 10442931.
DOI: 10.3389/fonc.2023.1173838.
Comparison of Laparoscopy and Laparotomy in the Management of Early-stage Ovarian Cancer.
Garcia N, Moreno C, Teixeira N, Lloret P, Guibourg R, Negre R
Gynecol Minim Invasive Ther. 2023; 12(2):83-89.
PMID: 37416098
PMC: 10321349.
DOI: 10.4103/gmit.gmit_99_22.
